This website uses cookies to improve your browsing experience. Please read our Privacy Policy for more information on what information we gather and how it is used.
Treatment Candidate

Metformin

Background

Metformin, an anti-diabetic medication, has shown anti-inflammatory properties that may reduce long COVID severity, particularly in patients with metabolic dysfunction.

Mechanism of Action

  • Metformin: Modulates metabolic pathways and reduces inflammation, potentially beneficial in mitigating post-viral symptoms (Metformin and COVID Study).

Pros and Cons

  • Pros: Oral administration and widely available; anti-inflammatory effects may support recovery.
  • Cons: Gastrointestinal side effects; lacks direct antiviral effects and may need to be combined with other treatments.

References

  1. Metformin and COVID Study

Stage
Pre-clinical
Category
Long-course antiviral
Ranking
5
Community Rating
5
Lead Researcher
Researcher
(No laboratory information available)
Laboratory
Laboratory
(No laboratory information available)
Funding
$
(No laboratory information available)

Join our community discussion and help us evaluate other treatment candidates

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ut venenatis enim. Suspendisse eu leo ipsum. Phasellus faucibus lorem sed mi varius pellentesque. Mauris vel elit tincidunt, pharetra arcu venenatis, mattis nisi.